Clinical trial Recruiting at 1 site Observational Ages 12 to 20

Effects of testosterone on headaches and brain development in transmasculine youth

Official title: Effect of Testosterone on Brain Imaging and Headache in Transmasculine Adolescents

Run by University of Colorado, Denver · NCT06670053 · Data updated 2026-11-12

This study is testing how testosterone therapy affects headaches and brain development in transmasculine youth aged 12-20 who were assigned female at birth.

More Headache trials

Quick facts

Study typeObservational
Ages12 Years to 20 Years
SexAll
Enrollment100 (estimated)
SponsorUniversity of Colorado, Denver
Academic / other
Locations1 site (Aurora, Colorado)
StatusRecruiting
StartedDecember 31, 2024
Main results expectedJune 2028
Study endsJanuary 2029
Registry record updatedSeptember 21, 2026
Trial IDNCT06670053 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are transmasculine youth aged 12-20 who are assigned female at birth and plan to start testosterone therapy within the next 6 months.

Probably not a fit

Patients with cognitive or psychiatric impairments, serious neurological conditions, or specific MRI exclusion criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the impact of testosterone therapy on headache patterns and brain development in transmasculine youth aged 12-20 who are assigned female at birth. Participants will undergo a series of assessments, including health surveys, brain MRIs, and blood samples, at four different time points: before starting testosterone and after 6 months, 1 year, and 2 years of treatment. The study aims to understand how testosterone influences headache experiences and brain structure during the initial years of hormone therapy. The research is conducted at Children's Hospital Colorado and involves close monitoring of participants' health and well-being.

Why it matters

Potential benefit: If successful, this study could provide insights into managing headaches and improving brain health in transmasculine youth undergoing hormone therapy.

How similar studies have gone: While studies have explored the effects of testosterone on pain in cisgender females and transmasculine adults, this specific approach in transmasculine youth is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. transmasculine and gender diverse
2. assigned female at birth
3. age 12-20 years at the time of enrollment
4. plan to start testosterone clinically in \< 6 months
5. if taking gonadotropin releasing hormone agonist (GnRHa, puberty blocker), was started on this type of drug 3+ months prior to enrollment

Exclusion Criteria:

1. cognitive or psychiatric impairment resulting in inability to tolerate or perform the study procedures
2. known history of stroke, multiple sclerosis, or other serious neurologic condition
3. prior diagnosis of Turner Syndrome (monosomy X) or other difference of sexual development
4. prior diagnosis of polycystic ovarian syndrome (PCOS)
5. uncontrolled or untreated hypothyroidism
6. MRI-specific exclusion criteria: (Weight \> 500 lbs, severe claustrophobia, certain type of metal in body)

Where it's running

  • Children's Hospital Colorado
    Aurora, Colorado, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.